Supplementary Materials and Methods and Figures from Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma

Liyuan Zheng,Wen Ye,WU Fu-quan,Chao Wang,Le-Xing Yu,Liang Tang,Bijun Qiu,Yuqiong Li,Lanping Guo,Mengchao Wu,Gen‐Sheng Feng,Dajin Zou,Hongyang Wang

DOI: https://doi.org/10.1158/1078-0432.22446918

2023-01-01

Abstract:PDF file, 983K, Supplemental Figure S1 p-AMPK/AMPK ratios of 19 HCC specimens. Supplemental Figure S2 Western blot analysis of p-AMPK(Thr172), PARP, CyclinD1. Supplemental Figure S3 AICAR inhibits human HCC cells growth. Supplemental Figure S4 Transfection of siRNA target AMPKalpha1 and AMPKalpha2 effectively knockdown expression of AMPK in SMMC7721 cells. Supplemental Figure S5 Metformin inhibits HCC cells growth via activation of AMPK. Supplemental Figure S6 Metformin causes cycle arrest and induces apoptosis in HCC cells. Supplemental Figure S7 Therapeutic metformin/AMPK activation sensitizes HCC cells towards chemotherapy. Supplemental Figure S8 Therapeutic metformin/AMPK activation inhibited IL-6/STAT3 signaling activity Supplemental Figure S9 Correlation between expression of p-AMPK (Thr172) and P65 nuclear staining in human HCC specimens. Supplemental Figure S10 AICAR treatment repressed NF-kappaB reporter gene activity. Supplemental Figure S11 SMMC7721 or HepG2 cells were transfected with vector, IkappaBalpha superrepressor (IkappaBalphaSR) or P65. Supplemental Figure S12 IkappaBalphaSR prevented metformin-induced upregulation of PTEN expression in SMMC7721 cells Supplemental Figure S13 Metformin did not significantly affect body weight, average blood glucose level and liver function of the mice. Supplemental Figure S14 Western blot analysis on the expressions of p-AMPK, p-PTEN, PTEN, p-STAT3 and STAT3 from respective cell homogenate Supplemental Table S1 Primer Sequences Used for RT-PCR.